Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.

Mnl Nominees Ltd (As Nominee For&On Behalf Of Eos Innovation Fund) investment portfolio

Mnl Nominees Ltd (As Nominee For&On Behalf Of Eos Innovation Fund) has made numerous investments in companies such as Scarlet Therapeutics, Camgene Therapeutics, and Concinnity Genetics within the Biotech sector.

vc
Portfolio
3
Team
0

Portfolio (3)

CompanySectorCitySourceLast confirmed on
Camgene Therapeutics Limited
CamGene Therapeutics Limited develops RNA‑based therapeutics aimed at treating hearing loss.
BiotechHealth Tech
CambridgeConfirmed2025-06-06
Concinnity Genetics Ltd
Concinnity Genetics creates AI‑driven RNA‑based gene control systems that enhance the safety and efficacy of gene and cell therapies, offering its technology to biotechnology and pharmaceutical companies developing gene‑therapy treatments.
Healthcare & Life SciencesEdinburghConfirmed2025-10-16

Sign up to see the full portfolio

+1 more company

Sign up

Backs Similar Companies

Investors who tend to invest in the same sort of companies.

5 more similar investors hiddenSign up to unlock →

Shareholding changes (3)

Mnl Nominees Ltd (As Nominee For&On Behalf Of Eos Innovation Fund)'s positions across portfolio companies
2026

Sign up free to see when this investor has bought or sold shares.

+1 more change

Sign up

Articles (4)